Biotech Congratulations on the positive phase I clinical results of Raymon Pharma’s first Chinese eye drops for the treatment of wAMD Bymedicilon June 15, 2023
Biotech Medicilon was honored again the “Top Ten Drug Innovation Service Institutions of the Year” of the Pharmaceutical Innovation Award Bymedicilon June 13, 2023June 13, 2023
Biotech Jingxin Pharmaceutical awarded the Medicilon DMPK team and the New Drug Registration Department the “Outstanding Contribution Team Award” Bymedicilon June 13, 2023
Biotech Medicilon interviewed Academician Biao Jiang | Co-founded Gluetacs Therapeutics to transform the scientific and technological achievements sleeping in the ivory tower Bymedicilon June 6, 2023June 13, 2023
Biotech Congratulations to Gluetacs Therapeutics’ new drug clinical research application for GT919, the first molecular glue degradation agent pipeline, approved by the FDA Bymedicilon June 6, 2023June 13, 2023
